| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $92.8M | +9.6% |
| SG&A Expense | $47.1M | +1.1% |
| Interest Expense | $229K | -44.7% |
| Income Tax | $0 | — |
| Net Income | -$135.8M | -4.1% |
| EPS (Basic) | -$2.03 | -3.0% |
| EPS (Diluted) | -$2.03 | -3.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $51.8M | -42.9% |
| Current Assets | $446.4M | -14.5% |
| Total Assets | $456.3M | -14.6% |
| Current Liabilities | $24.1M | +7.1% |
| Long-term Debt | $9.2M | — |
| Total Liabilities | $36.0M | +31.3% |
| Stockholders' Equity | $420.3M | -17.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$110.1M | -5.3% |
| Capital Expenditures | $626K | -45.4% |
| Investing Cash Flow | $32.6M | +125.7% |
| Financing Cash Flow | $38.6M | +1222.7% |
| Free Cash Flow | -$110.7M | -4.7% |